Yuichi Ando
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
- Oncology 19
- Cancer Immunotherapy and Biomarkers 9
-
- Gastric Cancer Management and Outcomes 5
- Sarcoma Diagnosis and Treatment 5
- Co-authors
- Osamu Maeda (17 shared papers)Hironobu Minami (6 shared papers)Satoshi Nishiwaki (1 shared paper)Naomi Kiyota (6 shared papers)Shunji Takahashi (4 shared papers)Hideo Saka (2 shared papers)Naoko Suenaga (1 shared paper)Satoru Iwasa (2 shared papers)
- Journals
- Cancer Science (6 papers)Journal of Clinical Oncology (3 papers)Japanese Journal of Clinical Oncology (2 papers)Annals of Oncology (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)
- Partner nations
- JapanUnited StatesSwitzerland
In The Last Decade
Yuichi Ando
41 papers receiving 317 citations
Peers
Comparison fields: 5 of 56
- Oncology 118
- Geriatrics and Gerontology 6
- Pulmonary and Respiratory Medicine 56
- Genetics 18
- Cancer Research 24
Countries citing papers authored by Yuichi Ando
This map shows the geographic impact of Yuichi Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichi Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichi Ando more than expected).
Fields of papers citing papers by Yuichi Ando
This network shows the impact of papers produced by Yuichi Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichi Ando. The network helps show where Yuichi Ando may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuichi Ando, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 43 | |
| 2 | 2011 | 40 | |
| 3 | 2022 | 38 | |
| 4 | 2021 | 22 | |
| 5 | 2021 | 20 | |
| 6 | 2020 | 17 | |
| 7 | 2020 | 16 | |
| 8 | 2020 | 11 | |
| 9 | 2020 | 11 | |
| 10 | 2022 | 8 | |
| 11 | 2024 | 7 | |
| 12 | 2019 | 7 | |
| 13 | 2018 | 6 | |
| 14 | 2019 | 6 | |
| 15 | 2020 | 6 | |
| 16 | 2022 | 5 | |
| 17 | 2021 | 4 | |
| 18 | 2021 | 4 | |
| 19 | 2022 | 4 | |
| 20 | 2024 | 4 |
About Yuichi Ando
Yuichi Ando is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Genetics, having authored 46 papers that have together received 324 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Chronic Lymphocytic Leukemia Research (6 papers), Gastric Cancer Management and Outcomes (5 papers), Sarcoma Diagnosis and Treatment (5 papers), Esophageal Cancer Research and Treatment (4 papers), Melanoma and MAPK Pathways (3 papers), Gastrointestinal Tumor Research and Treatment (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Oncology (118 citations), Geriatrics and Gerontology (6 citations), Pulmonary and Respiratory Medicine (56 citations), Genetics (18 citations) and Cancer Research (24 citations). Yuichi Ando has collaborated with scholars based in Japan, United States and Switzerland. Frequent co-authors include Osamu Maeda, Hironobu Minami, Satoshi Nishiwaki, Naomi Kiyota, Shunji Takahashi, Hideo Saka, Naoko Suenaga, Satoru Iwasa, Cornelia Quadt and Ayako Mitsuma. Their work appears in journals such as Cancer Science, Journal of Clinical Oncology, Japanese Journal of Clinical Oncology, Annals of Oncology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.